echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > This kind of low back pain, the first department is rheumatology! High risk of disability...

    This kind of low back pain, the first department is rheumatology! High risk of disability...

    • Last Update: 2022-10-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    *For medical professionals only

    Ankylosing spondylitis affects not only the spine, but also other organs
    .


    "Low back pain is common
    .


    Watch out for ankylosing spondylitis in these 4 conditions


    Ankylosing spondylitis is a group of chronic inflammatory diseases of the general term, with sacroiliac joint, spinal involvement as the main feature, can also affect peripheral joints or extra-articular tissues and organs, the prevalence rate in China is about 0.
    3%[1], the number of patients is about 3 million [2], more likely to occur in young men, usually the age of onset is 13 to 31 years old [1].



    The onset of ankylosing spondylitis is insidious, and the early symptoms are not very typical, but its painful "characteristics" still have a way to distinguish it in Professor Zhang Xuewu's view:

    First, unexplained low back pain lasts for 3 months and more;


    Secondly, the pain intensifies at night, and severe pain may wake up in the middle of the night;


    There is also the back stiffness (morning stiffness) when you wake up in the morning, and exercise can relieve pain, which is characteristic of
    inflammatory pain.



    In addition to low back pain, some patients will also have some large joint pain in the limbs, such as neck, knee joint, heel pain and so on
    .


    In addition to the pain, it also affects other organs


    Ankylosing spondylitis affects not only the spine, but also other organs
    .


    Ankylosing spondylitis can harm not only pain, but also spinal destruction
    caused by long-term inflammation.


    Controlling symptoms and protecting structures are the main goals
    "Ankylosing spondylitis has no cure or drug, and the current advocacy is to achieve standard treatment
    .


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.